This mutant IDH1/2 had higher expression level of p53 and longer recurrence time and survival time than wild-type IDH1/2, suggesting that hypermethylated CCA may represent a different molecular subclass with a better prognosis [59]. This evidence concerns the gene IDH1 and cholangiocarcinoma.